Another study showed that circRIP2 activity accelerates bladder cancer progression via inducing the epithelial-mesenchymal transition (EMT) by activating the miR-1305/Tgf-β2/smad3 pathway.17 Here, SMAD3 is linked to urinary bladder cancer.